Liquid Biopsy Products-Global Market Status and Trend Report 2013-2023
Report Summary
Liquid Biopsy Products-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Liquid Biopsy Products industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Liquid Biopsy Products 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Liquid Biopsy Products worldwide, with company and product introduction, position in the Liquid Biopsy Products market
Market status and development trend of Liquid Biopsy Products by types and applications
Cost and profit status of Liquid Biopsy Products, and marketing status
Market growth drivers and challenges
The report segments the global Liquid Biopsy Products market as:
Global Liquid Biopsy Products Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Liquid Biopsy Products Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
CTC
ctDNA
Exosomes
Global Liquid Biopsy Products Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Blood Sample
Urine Sample
Other
Global Liquid Biopsy Products Market: Manufacturers Segment Analysis (Company and Product introduction, Liquid Biopsy Products Sales Volume, Revenue, Price and Gross Margin):
RainDance Technologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Liquid Biopsy Products-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Liquid Biopsy Products industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Liquid Biopsy Products 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Liquid Biopsy Products worldwide, with company and product introduction, position in the Liquid Biopsy Products market
Market status and development trend of Liquid Biopsy Products by types and applications
Cost and profit status of Liquid Biopsy Products, and marketing status
Market growth drivers and challenges
The report segments the global Liquid Biopsy Products market as:
Global Liquid Biopsy Products Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Liquid Biopsy Products Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
CTC
ctDNA
Exosomes
Global Liquid Biopsy Products Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Blood Sample
Urine Sample
Other
Global Liquid Biopsy Products Market: Manufacturers Segment Analysis (Company and Product introduction, Liquid Biopsy Products Sales Volume, Revenue, Price and Gross Margin):
RainDance Technologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF LIQUID BIOPSY PRODUCTS
1.1 Definition of Liquid Biopsy Products in This Report
1.2 Commercial Types of Liquid Biopsy Products
1.2.1 CTC
1.2.2 ctDNA
1.2.3 Exosomes
1.3 Downstream Application of Liquid Biopsy Products
1.3.1 Blood Sample
1.3.2 Urine Sample
1.3.3 Other
1.4 Development History of Liquid Biopsy Products
1.5 Market Status and Trend of Liquid Biopsy Products 2013-2023
1.5.1 Global Liquid Biopsy Products Market Status and Trend 2013-2023
1.5.2 Regional Liquid Biopsy Products Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Liquid Biopsy Products 2013-2017
2.2 Sales Market of Liquid Biopsy Products by Regions
2.2.1 Sales Volume of Liquid Biopsy Products by Regions
2.2.2 Sales Value of Liquid Biopsy Products by Regions
2.3 Production Market of Liquid Biopsy Products by Regions
2.4 Global Market Forecast of Liquid Biopsy Products 2018-2023
2.4.1 Global Market Forecast of Liquid Biopsy Products 2018-2023
2.4.2 Market Forecast of Liquid Biopsy Products by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Liquid Biopsy Products by Types
3.2 Sales Value of Liquid Biopsy Products by Types
3.3 Market Forecast of Liquid Biopsy Products by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Liquid Biopsy Products by Downstream Industry
4.2 Global Market Forecast of Liquid Biopsy Products by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Liquid Biopsy Products Market Status by Countries
5.1.1 North America Liquid Biopsy Products Sales by Countries (2013-2017)
5.1.2 North America Liquid Biopsy Products Revenue by Countries (2013-2017)
5.1.3 United States Liquid Biopsy Products Market Status (2013-2017)
5.1.4 Canada Liquid Biopsy Products Market Status (2013-2017)
5.1.5 Mexico Liquid Biopsy Products Market Status (2013-2017)
5.2 North America Liquid Biopsy Products Market Status by Manufacturers
5.3 North America Liquid Biopsy Products Market Status by Type (2013-2017)
5.3.1 North America Liquid Biopsy Products Sales by Type (2013-2017)
5.3.2 North America Liquid Biopsy Products Revenue by Type (2013-2017)
5.4 North America Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Liquid Biopsy Products Market Status by Countries
6.1.1 Europe Liquid Biopsy Products Sales by Countries (2013-2017)
6.1.2 Europe Liquid Biopsy Products Revenue by Countries (2013-2017)
6.1.3 Germany Liquid Biopsy Products Market Status (2013-2017)
6.1.4 UK Liquid Biopsy Products Market Status (2013-2017)
6.1.5 France Liquid Biopsy Products Market Status (2013-2017)
6.1.6 Italy Liquid Biopsy Products Market Status (2013-2017)
6.1.7 Russia Liquid Biopsy Products Market Status (2013-2017)
6.1.8 Spain Liquid Biopsy Products Market Status (2013-2017)
6.1.9 Benelux Liquid Biopsy Products Market Status (2013-2017)
6.2 Europe Liquid Biopsy Products Market Status by Manufacturers
6.3 Europe Liquid Biopsy Products Market Status by Type (2013-2017)
6.3.1 Europe Liquid Biopsy Products Sales by Type (2013-2017)
6.3.2 Europe Liquid Biopsy Products Revenue by Type (2013-2017)
6.4 Europe Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Liquid Biopsy Products Market Status by Countries
7.1.1 Asia Pacific Liquid Biopsy Products Sales by Countries (2013-2017)
7.1.2 Asia Pacific Liquid Biopsy Products Revenue by Countries (2013-2017)
7.1.3 China Liquid Biopsy Products Market Status (2013-2017)
7.1.4 Japan Liquid Biopsy Products Market Status (2013-2017)
7.1.5 India Liquid Biopsy Products Market Status (2013-2017)
7.1.6 Southeast Asia Liquid Biopsy Products Market Status (2013-2017)
7.1.7 Australia Liquid Biopsy Products Market Status (2013-2017)
7.2 Asia Pacific Liquid Biopsy Products Market Status by Manufacturers
7.3 Asia Pacific Liquid Biopsy Products Market Status by Type (2013-2017)
7.3.1 Asia Pacific Liquid Biopsy Products Sales by Type (2013-2017)
7.3.2 Asia Pacific Liquid Biopsy Products Revenue by Type (2013-2017)
7.4 Asia Pacific Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Liquid Biopsy Products Market Status by Countries
8.1.1 Latin America Liquid Biopsy Products Sales by Countries (2013-2017)
8.1.2 Latin America Liquid Biopsy Products Revenue by Countries (2013-2017)
8.1.3 Brazil Liquid Biopsy Products Market Status (2013-2017)
8.1.4 Argentina Liquid Biopsy Products Market Status (2013-2017)
8.1.5 Colombia Liquid Biopsy Products Market Status (2013-2017)
8.2 Latin America Liquid Biopsy Products Market Status by Manufacturers
8.3 Latin America Liquid Biopsy Products Market Status by Type (2013-2017)
8.3.1 Latin America Liquid Biopsy Products Sales by Type (2013-2017)
8.3.2 Latin America Liquid Biopsy Products Revenue by Type (2013-2017)
8.4 Latin America Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Liquid Biopsy Products Market Status by Countries
9.1.1 Middle East and Africa Liquid Biopsy Products Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Liquid Biopsy Products Revenue by Countries (2013-2017)
9.1.3 Middle East Liquid Biopsy Products Market Status (2013-2017)
9.1.4 Africa Liquid Biopsy Products Market Status (2013-2017)
9.2 Middle East and Africa Liquid Biopsy Products Market Status by Manufacturers
9.3 Middle East and Africa Liquid Biopsy Products Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Liquid Biopsy Products Sales by Type (2013-2017)
9.3.2 Middle East and Africa Liquid Biopsy Products Revenue by Type (2013-2017)
9.4 Middle East and Africa Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF LIQUID BIOPSY PRODUCTS
10.1 Global Economy Situation and Trend Overview
10.2 Liquid Biopsy Products Downstream Industry Situation and Trend Overview
CHAPTER 11 LIQUID BIOPSY PRODUCTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Liquid Biopsy Products by Major Manufacturers
11.2 Production Value of Liquid Biopsy Products by Major Manufacturers
11.3 Basic Information of Liquid Biopsy Products by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Liquid Biopsy Products Major Manufacturer
11.3.2 Employees and Revenue Level of Liquid Biopsy Products Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 LIQUID BIOPSY PRODUCTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 RainDance Technologies
12.1.1 Company profile
12.1.2 Representative Liquid Biopsy Products Product
12.1.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of RainDance Technologies
12.2 Biocartis
12.2.1 Company profile
12.2.2 Representative Liquid Biopsy Products Product
12.2.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Biocartis
12.3 Qiagen
12.3.1 Company profile
12.3.2 Representative Liquid Biopsy Products Product
12.3.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Qiagen
12.4 Guardant Health
12.4.1 Company profile
12.4.2 Representative Liquid Biopsy Products Product
12.4.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Guardant Health
12.5 MDxHealth
12.5.1 Company profile
12.5.2 Representative Liquid Biopsy Products Product
12.5.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of MDxHealth
12.6 Pathway Genomics
12.6.1 Company profile
12.6.2 Representative Liquid Biopsy Products Product
12.6.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Pathway Genomics
12.7 NeoGenomics Laboraories
12.7.1 Company profile
12.7.2 Representative Liquid Biopsy Products Product
12.7.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of NeoGenomics Laboraories
12.8 Sysmex Inostics
12.8.1 Company profile
12.8.2 Representative Liquid Biopsy Products Product
12.8.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Sysmex Inostics
12.9 Cynvenio
12.9.1 Company profile
12.9.2 Representative Liquid Biopsy Products Product
12.9.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Cynvenio
12.10 Menarini Silicon Biosystems
12.10.1 Company profile
12.10.2 Representative Liquid Biopsy Products Product
12.10.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Menarini Silicon Biosystems
12.11 Adaptive Biotechnologies
12.11.1 Company profile
12.11.2 Representative Liquid Biopsy Products Product
12.11.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Adaptive Biotechnologies
12.12 Biocept
12.12.1 Company profile
12.12.2 Representative Liquid Biopsy Products Product
12.12.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Biocept
12.13 Angle plc
12.13.1 Company profile
12.13.2 Representative Liquid Biopsy Products Product
12.13.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Angle plc
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF LIQUID BIOPSY PRODUCTS
13.1 Industry Chain of Liquid Biopsy Products
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF LIQUID BIOPSY PRODUCTS
14.1 Cost Structure Analysis of Liquid Biopsy Products
14.2 Raw Materials Cost Analysis of Liquid Biopsy Products
14.3 Labor Cost Analysis of Liquid Biopsy Products
14.4 Manufacturing Expenses Analysis of Liquid Biopsy Products
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Liquid Biopsy Products in This Report
1.2 Commercial Types of Liquid Biopsy Products
1.2.1 CTC
1.2.2 ctDNA
1.2.3 Exosomes
1.3 Downstream Application of Liquid Biopsy Products
1.3.1 Blood Sample
1.3.2 Urine Sample
1.3.3 Other
1.4 Development History of Liquid Biopsy Products
1.5 Market Status and Trend of Liquid Biopsy Products 2013-2023
1.5.1 Global Liquid Biopsy Products Market Status and Trend 2013-2023
1.5.2 Regional Liquid Biopsy Products Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Liquid Biopsy Products 2013-2017
2.2 Sales Market of Liquid Biopsy Products by Regions
2.2.1 Sales Volume of Liquid Biopsy Products by Regions
2.2.2 Sales Value of Liquid Biopsy Products by Regions
2.3 Production Market of Liquid Biopsy Products by Regions
2.4 Global Market Forecast of Liquid Biopsy Products 2018-2023
2.4.1 Global Market Forecast of Liquid Biopsy Products 2018-2023
2.4.2 Market Forecast of Liquid Biopsy Products by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Liquid Biopsy Products by Types
3.2 Sales Value of Liquid Biopsy Products by Types
3.3 Market Forecast of Liquid Biopsy Products by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Liquid Biopsy Products by Downstream Industry
4.2 Global Market Forecast of Liquid Biopsy Products by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Liquid Biopsy Products Market Status by Countries
5.1.1 North America Liquid Biopsy Products Sales by Countries (2013-2017)
5.1.2 North America Liquid Biopsy Products Revenue by Countries (2013-2017)
5.1.3 United States Liquid Biopsy Products Market Status (2013-2017)
5.1.4 Canada Liquid Biopsy Products Market Status (2013-2017)
5.1.5 Mexico Liquid Biopsy Products Market Status (2013-2017)
5.2 North America Liquid Biopsy Products Market Status by Manufacturers
5.3 North America Liquid Biopsy Products Market Status by Type (2013-2017)
5.3.1 North America Liquid Biopsy Products Sales by Type (2013-2017)
5.3.2 North America Liquid Biopsy Products Revenue by Type (2013-2017)
5.4 North America Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Liquid Biopsy Products Market Status by Countries
6.1.1 Europe Liquid Biopsy Products Sales by Countries (2013-2017)
6.1.2 Europe Liquid Biopsy Products Revenue by Countries (2013-2017)
6.1.3 Germany Liquid Biopsy Products Market Status (2013-2017)
6.1.4 UK Liquid Biopsy Products Market Status (2013-2017)
6.1.5 France Liquid Biopsy Products Market Status (2013-2017)
6.1.6 Italy Liquid Biopsy Products Market Status (2013-2017)
6.1.7 Russia Liquid Biopsy Products Market Status (2013-2017)
6.1.8 Spain Liquid Biopsy Products Market Status (2013-2017)
6.1.9 Benelux Liquid Biopsy Products Market Status (2013-2017)
6.2 Europe Liquid Biopsy Products Market Status by Manufacturers
6.3 Europe Liquid Biopsy Products Market Status by Type (2013-2017)
6.3.1 Europe Liquid Biopsy Products Sales by Type (2013-2017)
6.3.2 Europe Liquid Biopsy Products Revenue by Type (2013-2017)
6.4 Europe Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Liquid Biopsy Products Market Status by Countries
7.1.1 Asia Pacific Liquid Biopsy Products Sales by Countries (2013-2017)
7.1.2 Asia Pacific Liquid Biopsy Products Revenue by Countries (2013-2017)
7.1.3 China Liquid Biopsy Products Market Status (2013-2017)
7.1.4 Japan Liquid Biopsy Products Market Status (2013-2017)
7.1.5 India Liquid Biopsy Products Market Status (2013-2017)
7.1.6 Southeast Asia Liquid Biopsy Products Market Status (2013-2017)
7.1.7 Australia Liquid Biopsy Products Market Status (2013-2017)
7.2 Asia Pacific Liquid Biopsy Products Market Status by Manufacturers
7.3 Asia Pacific Liquid Biopsy Products Market Status by Type (2013-2017)
7.3.1 Asia Pacific Liquid Biopsy Products Sales by Type (2013-2017)
7.3.2 Asia Pacific Liquid Biopsy Products Revenue by Type (2013-2017)
7.4 Asia Pacific Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Liquid Biopsy Products Market Status by Countries
8.1.1 Latin America Liquid Biopsy Products Sales by Countries (2013-2017)
8.1.2 Latin America Liquid Biopsy Products Revenue by Countries (2013-2017)
8.1.3 Brazil Liquid Biopsy Products Market Status (2013-2017)
8.1.4 Argentina Liquid Biopsy Products Market Status (2013-2017)
8.1.5 Colombia Liquid Biopsy Products Market Status (2013-2017)
8.2 Latin America Liquid Biopsy Products Market Status by Manufacturers
8.3 Latin America Liquid Biopsy Products Market Status by Type (2013-2017)
8.3.1 Latin America Liquid Biopsy Products Sales by Type (2013-2017)
8.3.2 Latin America Liquid Biopsy Products Revenue by Type (2013-2017)
8.4 Latin America Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Liquid Biopsy Products Market Status by Countries
9.1.1 Middle East and Africa Liquid Biopsy Products Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Liquid Biopsy Products Revenue by Countries (2013-2017)
9.1.3 Middle East Liquid Biopsy Products Market Status (2013-2017)
9.1.4 Africa Liquid Biopsy Products Market Status (2013-2017)
9.2 Middle East and Africa Liquid Biopsy Products Market Status by Manufacturers
9.3 Middle East and Africa Liquid Biopsy Products Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Liquid Biopsy Products Sales by Type (2013-2017)
9.3.2 Middle East and Africa Liquid Biopsy Products Revenue by Type (2013-2017)
9.4 Middle East and Africa Liquid Biopsy Products Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF LIQUID BIOPSY PRODUCTS
10.1 Global Economy Situation and Trend Overview
10.2 Liquid Biopsy Products Downstream Industry Situation and Trend Overview
CHAPTER 11 LIQUID BIOPSY PRODUCTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Liquid Biopsy Products by Major Manufacturers
11.2 Production Value of Liquid Biopsy Products by Major Manufacturers
11.3 Basic Information of Liquid Biopsy Products by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Liquid Biopsy Products Major Manufacturer
11.3.2 Employees and Revenue Level of Liquid Biopsy Products Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 LIQUID BIOPSY PRODUCTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 RainDance Technologies
12.1.1 Company profile
12.1.2 Representative Liquid Biopsy Products Product
12.1.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of RainDance Technologies
12.2 Biocartis
12.2.1 Company profile
12.2.2 Representative Liquid Biopsy Products Product
12.2.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Biocartis
12.3 Qiagen
12.3.1 Company profile
12.3.2 Representative Liquid Biopsy Products Product
12.3.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Qiagen
12.4 Guardant Health
12.4.1 Company profile
12.4.2 Representative Liquid Biopsy Products Product
12.4.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Guardant Health
12.5 MDxHealth
12.5.1 Company profile
12.5.2 Representative Liquid Biopsy Products Product
12.5.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of MDxHealth
12.6 Pathway Genomics
12.6.1 Company profile
12.6.2 Representative Liquid Biopsy Products Product
12.6.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Pathway Genomics
12.7 NeoGenomics Laboraories
12.7.1 Company profile
12.7.2 Representative Liquid Biopsy Products Product
12.7.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of NeoGenomics Laboraories
12.8 Sysmex Inostics
12.8.1 Company profile
12.8.2 Representative Liquid Biopsy Products Product
12.8.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Sysmex Inostics
12.9 Cynvenio
12.9.1 Company profile
12.9.2 Representative Liquid Biopsy Products Product
12.9.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Cynvenio
12.10 Menarini Silicon Biosystems
12.10.1 Company profile
12.10.2 Representative Liquid Biopsy Products Product
12.10.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Menarini Silicon Biosystems
12.11 Adaptive Biotechnologies
12.11.1 Company profile
12.11.2 Representative Liquid Biopsy Products Product
12.11.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Adaptive Biotechnologies
12.12 Biocept
12.12.1 Company profile
12.12.2 Representative Liquid Biopsy Products Product
12.12.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Biocept
12.13 Angle plc
12.13.1 Company profile
12.13.2 Representative Liquid Biopsy Products Product
12.13.3 Liquid Biopsy Products Sales, Revenue, Price and Gross Margin of Angle plc
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF LIQUID BIOPSY PRODUCTS
13.1 Industry Chain of Liquid Biopsy Products
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF LIQUID BIOPSY PRODUCTS
14.1 Cost Structure Analysis of Liquid Biopsy Products
14.2 Raw Materials Cost Analysis of Liquid Biopsy Products
14.3 Labor Cost Analysis of Liquid Biopsy Products
14.4 Manufacturing Expenses Analysis of Liquid Biopsy Products
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
